Search Options Stock News and Analysis

The Options Strategy Perfect for Volatile Markets

https://www.schaeffersresearch.com/content/options/2020/03/27/the-options-strategy-perfect-for-volatile-markets

3/27/2020 12:45 PM

A long volatility/ straddle strategy might be a good idea for the current roller-coaster market environment we're experiencing. Having a set allocation of your portfolio with these types of trades can...

Stocks Hesitate with Trade and OPEC in Focus

https://www.schaeffersresearch.com/content/ezines/2019/12/05/stocks-hesitate-with-trade-and-opec-in-focus

12/5/2019 11:54 AM

Stocks are generally searching for direction at midday, as investors consider a muddied outlook for U.S.-China trade talks. The Dow Jones Industrial Average (DJI), S&P 500 Index (SPX), and Nasdaq...

SAGE Stock Gets Boost on FDA Approval

https://www.schaeffersresearch.com/content/news/2019/03/20/sage-stock-gets-boost-on-fda-approval

3/20/2019 9:37 AM

The shares of SAGE Therapeutics Inc (NASDAQ:SAGE) are up 2% at $159.20, after its postpartum depression (PPD) drug, Zulresso, was approved by the Food and Drug Administration (FDA). Some experts' ne...

Stock Futures Inch Higher Ahead of Fed Decision

https://www.schaeffersresearch.com/content/ezines/2019/03/20/stock-futures-inch-higher-ahead-of-fed-decision

3/20/2019 9:21 AM

Dow Jones Industrial Average (DJI) futures are trading cautiously above fair value ahead of the final day of the Fed meeting. While next to no one is expecting an interest rate hike, investors are s...

SAGE Therapeutics Stock Hot Ahead of Earnings

https://www.schaeffersresearch.com/content/analysis/2019/02/15/sage-therapeutics-stock-hot-ahead-of-earnings

2/15/2019 1:10 PM

Up 0.8% at $159.30, at last check, drug name SAGE Therapeutics Inc (NASDAQ:SAGE) is scheduled to report fourth-quarter earnings before the market opens on Tuesday, Feb. 19. Below, we will take a look...

PEOPLE ALSO SEARCH FOR